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Case Report
Introduction
Talc is composed of crystallized magnesium silicate and is 
found in common household items such as baby powder, 
cosmetics, and pharmaceutical tablets.1 Talc is a known 
cause of pulmonary foreign-body granulomatosis in intrave-
nous drug users, mainly from talc binders present in dis-
solved prescription drugs. Less commonly, inhalation of talc 
can lead to pulmonary foreign-body granulomatosis, though 
fewer than 10 cases have been reported in adults. Inhaled 
pulmonary talcosis is often treated with oral corticosteroids, 
though supportive data for this practice is limited.
Case Report
We report the case of a 64-year-old Caucasian man with a 
50 pack-year history of tobacco abuse and obstructive 
sleep apnea on nocturnal continuous positive airway pres-
sure who presented to pulmonology clinic with indolent, 
worsening shortness of breath and productive cough over 
the preceding year. The patient was a retired auto-
mechanic with previous reported asbestos exposure from 
car brakes. He had no other significant exposure history. 
Physical exam included fine rales at both lung bases. 
Computed tomography (CT) of the chest showed diffuse, 
bilateral pulmonary nodules, hilar and mediastinal lymph-
adenopathy, and scattered ground glass opacities, which 
were new in comparison to his previous chest CT 2 years 
prior to this encounter (Figure 1). Bronchoalveolar lavage 
(BAL) showed a predominance of neutrophils, as shown 
in Table 1. Transbronchial biopsy showed a foreign-body 
giant cell reaction with intracellular round to oval polariz-
able material (Figure 2). Our facilities did not have the 
capability to perform birefringence testing on a routine 
basis, and therefore it was not done.
Further history revealed that the patient was applying copi-
ous amounts of baby powder to his bed-bound wife twice daily 
for the last year, which corresponded to the period of symptom 
onset and worsening. A diagnosis of inhaled cosmetic talc–
related pulmonary granulomatosis (ICTRPG) was made. Over 
the 9 months following cessation of talc exposure, the patient 
demonstrated progressive symptomatic improvement without 
the use of corticosteroids. Repeat CT of the chest showed a 
decrease in the size and number of multiple bilateral pulmo-
nary nodules, and resolution of ground glass opacities.
Discussion
Inhaled talc pneumoconiosis was first described by Thorel 
in 1896.2 Most cases of foreign-body granulomatosis from 
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Abstract
Inhalation of cosmetic talc can lead to pulmonary foreign-body granulomatosis, though fewer than 10 cases of inhaled cosmetic 
talc–related pulmonary granulomatosis have been reported in adults. We report the case of a 64-year-old man with diffuse, 
bilateral pulmonary nodules and ground glass opacities associated with chronic inhalation of cosmetic talc. Transbronchial 
biopsy showed peribronchiolar foreign-body granulomas. After cessation of talc exposure, the patient demonstrated clinical 
and radiographic improvement without the use of corticosteroids. This case demonstrates that a conservative approach 
with cessation of exposure alone, without the use of corticosteroids, can be an effective therapy in cosmetic talc–related 
pulmonary granulomatosis.
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talc are due to either occupational exposure to talc or intra-
venous injection of talc-containing oral tablets.1 There are 
4 forms of talc-induced lung injury, 3 of which involve 
inhalation.1 The first form, known as talc asbestosis, occurs 
with inhalation of talc with asbestiform fibers, mimicking 
pulmonary asbestosis.3 During production of commercial 
talc, thin, elongated talc crystal cleavage fragments are 
created that meet the World Health Organization definition 
of fibers.3 These fibers deposit in the small airways and 
alveoli leading to a fibrotic reaction over time. The second 
form, talcosilicosis, occurs after talc with a high silica con-
tent (a by-product of mining talc) is repeatedly inhaled over 
time. Clinically, talcosilicosis is indistinguishable from sili-
cosis, producing nodules and, occasionally, fibrosis involv-
ing the mid- to upper-lung zones.4 The third and rarest 
form, talcosis, occurs with inhalation of pure talc (described 
in more detail below). The fourth form, seen after intrave-
nous use of crushed opiate pills, leads to perivascular pul-
monary granulomas.5 These granulomas are thought to 
result from a delayed hypersensitivity reaction that mani-
fests as epithelioid cells and foreign-body giant cells.6
Inhalation of cosmetic talc presents with a wide variety of 
nonspecific clinical symptoms including dyspnea on exer-
tion, cough, chest pain, weight loss, anorexia, low-grade 
fevers, and night sweats.1,7-9 Symptoms typically develop 
shortly after exposure, but can manifest up to 30 years later 
posing a significant diagnostic challenge.1 Pulmonary hyper-
tension, emphysema, and chronic respiratory failure may 
occur after long-term exposure.10 In some cases, death attrib-
uted to talc exposure may occur.7
Inhalation talcosis typically demonstrates solid nodules 
and ground glass opacities distributed throughout all lung 
zones on chest CT.7,10 In contrast, talcosilicosis and talc 
asbestosis appear indistinguishable from silicosis and asbes-
tosis, respectively. Imaging of patients with talc granuloma-
tosis from intravenous injection can show dense nodules, 
masses, and lower lobe predominant emphysema.7,10 All 
forms of talcosis can lead to pulmonary fibrosis.
ICTRPG pathology demonstrates nonnecrotizing granu-
lomas with multinucleated foreign-body giant cells contain-
ing birefringent foreign bodies under polarized light.7,11 
Table 1. Bronchoalveolar Lavage.
White blood cell count (/mm3) 213
Neutrophils (%) 90%
Lymphocytes (%) 2%
Monocytes (%) 3%
Eosinophils (%) 3%
Histiocytes (%) 2%
Red blood cell count (/mm3) 11 250
Cultures (bacterial, AFB, fungal) Samples lost
Figure 2. Transbronchial biopsy with hematoxylin-eosin staining 
showing foreign-body giant cell reaction containing round to oval 
polarizable material (black arrow) and foreign-body granuloma 
(red arrow).
Figure 1. Left: CT chest on presentation. Note the diffuse poorly defined nodules and ground glass opacities. Right: CT chest 9 months 
after cessation of cosmetic talc use, demonstrating resolution of ground glass opacities and smaller, less dense nodules.
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ICTRPG-associated foreign-body granulomas are typically 
found surrounding small airways and alveolar septae, with 
larger nodules resulting from the coalescence of granulomas 
in chronic disease.7 In contrast, foreign-body granulomatosis 
from intravenous injection of talc (eg, from dissolved opioid 
pharmaceutical tablets) results in granuloma formation in a 
perivascular pattern that spreads into the interstitium. 
Crystals are larger in intravenous exposure compared with 
inhalational exposure.7 Ultimately, interstitial fibrosis can 
develop in both forms of talc exposure.7 In all cases, it is 
important to exclude other causes of nonnecrotizing granulo-
mas with or without foreign bodies, including chronic aspira-
tion and sarcoidosis. The clinical history of inhalational talc 
exposure, absence of alternative diagnoses, and a normal 
swallowing mechanism are usually sufficient to make the 
diagnosis of ICTRPG.
Numerous cases of ICTRPG have demonstrated persis-
tent granulomatosis and pulmonary fibrosis despite cessation 
of exposure to cosmetic talc.9,12,13 Cruthirds et al described a 
2-year-old patient with a massive talc aspiration leading to 
pulmonary fibrosis. Despite functional improvement, the 
patient subsequently developed pulmonary hypertension 16 
years after the exposure event.12 van Huisstede et al described 
a patient with perceived improvement, although her imaging 
showed stable, unchanged nodular lesions in bilateral lung 
fields despite cessation of cosmetic talc use.13 In contrast, 
our case demonstrates both symptomatic and radiographic 
improvement with cessation of exposure, an outcome that 
has not been documented in previous cases of ICTRPG.
Corticosteroids are used to treat ICTRPG based on case 
reports and expert opinion.8,14 Iqbal et al described a case of 
ICTRPG in which the initial use of prednisolone resulted in 
symptomatic improvement; however, cessation of the corti-
costeroid led to recurrence of symptoms indicating that talc 
exposure was ongoing or that talc-related inflammation was 
not fully suppressed.6 Conversely, Ong and Takano described 
a case of ICTRPG in which the use of prednisolone with a 
slow taper resulted in improvement in symptoms, lung func-
tion, and radiographic findings.14
An apt comparison for ICTRPG is with extrinsic allergic 
alveolitis, also known as hypersensitivity pneumonitis (HP). 
While talc is not traditionally considered one of the antigens 
leading to HP, ICTRPG resembles HP in many respects. 
Both are immune reactions to inhaled antigens leading to 
bronchiolocenteric nonnecrotizing granulomas. In addition, 
both have acute and chronic forms, with radiographic find-
ings of ground glass opacities and centrilobular nodules.15 
While HP and ICTRPG are different immunologically, their 
clinical presentations are almost identical, as demonstrated 
in Table 2. The pathogenesis of HP is thought of as a 2-hit 
model where a genetically predisposed patient is exposed to 
an antigen, leading to pneumonitis and possibly pulmonary 
fibrosis.15 In acute HP, the disease process is mediated by an 
immune complex response. In subacute and chronic HP, the 
disease process is mediated by T-lymphocytes via a Th1 
response cascade.15,16 Conversely, the immunologic patho-
genesis of ICTRPG is not well understood, but is thought to 
be a hypersensitivity reaction leading to granuloma forma-
tion via foreign-body giant cells and macrophages.6,9,13,14 
Corticosteroids may accelerate improvement in lung func-
tion for acute HP but long-term survival benefit has not been 
proven.17 The most effective intervention in HP remains ces-
sation of exposure to the inciting antigen.15,17
Our case suggests overlap between these 2 diseases in 
terms of symptoms and radiographic findings, with the nota-
ble exception of the neutrophilic predominance in the BAL 
fluid (Table 1). Bronchoscopy in HP typically shows a 
T-lymphocyte predominance on BAL, which is highly sensi-
tive but poorly specific for the diagnosis of acute HP.15,18 
While a high antigen load or coexistent infection may cause 
an airway neutrophilia on BAL in HP, infection was not found 
in our patient.19 Beck et al examined the effects of inhaled talc 
and granite in a hamster model. Both talc and granite led to 
high alveolar neutrophil and decreased macrophage levels, 
although the effect was more transient with talc.20
The limitations of our case include inability to perform 
birefringence and lack of culture data from BAL because the 
samples were lost. Clinically, the patient did not appear 
infected and he improved without antimicrobial treatment. 
Furthermore, after 9 months of follow-up, the patient failed 
to return to clinic limiting our ability to assess longer term 
outcomes. We also do not know what brand of cosmetic talc 
Table 2. A Comparison Between Talc Pneumonitis and Acute Hypersensitivity Pneumonitis.
Talc Pneumonitis Acute Hypersensitivity Pneumonitis
Symptoms Dyspnea, nonproductive cough Dyspnea, nonproductive cough
Chest radiography Peribronchial reticulonodular infiltration, sparing of apices, 
and costophrenic angles13
Peribronchial reticulonodular 
infiltration (patchy or diffuse)
High-resolution computed 
tomography scan
Scattered ground glass opacities, nodules Scattered ground glass opacities, 
nodules
Pulmonary function test Restrictive pattern Restrictive pattern
Bronchoalveolar lavage Neutrophilic predominance Lymphocytic predominance
Pathology Nonnecrotizing granulomas with multinucleated foreign-body 
giant cells containing birefringent foreign bodies under 
polarized light surrounding small airways and alveolar septae
Loosely formed nonnecrotizing 
granulomas
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he was using, and therefore, we do not know if the inhaled 
talc contained asbestiform particles. However, asbestiform 
contamination is unlikely given imaging that was not consis-
tent with talcoasbestosis.
In our patient, we chose to remove the inciting agent with-
out pharmacologic intervention given the risks of corticoste-
roid use in the context of his comorbidities. Our patient did 
not demonstrate radiographic evidence of fibrosis— a 
described sequelae of talc inhalation—possibly contributing 
to the reversibility of his disease. To our knowledge, this is 
the first published case of ICTRPG successfully treated solely 
with antigen removal, and it is likely that other cases of mild 
to moderate disease may be managed in a similar way.
Conclusion
Our case demonstrates that cessation of cosmetic talc expo-
sure, without the use of corticosteroids, can be an effective 
therapy in ICTRPG without fibrosis. While ICTRPG shares 
many characteristics with HP, this case shows that ICTRPG 
may present with a predominance of alveolar neutrophils on 
BAL, possibly a direct result of either recent or frequent talc 
exposure.
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